E7
E7T.F Alexium International Group Limited
- Market cap
- EUR 1.59M
- P/E
- -
- P/B
- 0.53x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is E7T.F undervalued?
Graham numberThe Graham number of Alexium International Group Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Alexium International Group Limited fundamental analysis
No fundamental analysis for Alexium International Group Limited yet.
Alexium International Group Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Alexium International Group Limited
Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; Eclipsys, a perpetual cooling technology that enhance the cooling experience; and DelCool, a thermal management product. The company also…
Full company profileAlexium International Group Limited financial statements
Alexium International Group Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 23.8M | 16.1M | 7.21M | 8.86M | 7.28M | 8.17M | 7.21M | 5.89M | 3.92M | 4.23M |
| Gross Profit | 296K | 3.19M | 2.29M | 3.37M | 2.64M | 3.33M | 2.82M | 2.64M | 1.69M | 1.22M |
| Operating Income | -12.2M | -6.02M | -6.85M | -3.95M | -2.74M | -2.25M | -2.20M | -2.45M | -3.16M | -4.52M |
| EBITDA | -11.8M | -2.24M | -5.91M | -6.15M | -763K | -1.54M | -1.38M | -962K | -3.25M | -5.78M |
| Net Income | -12.2M | -5.36M | -9.90M | -8.93M | -1.45M | -3.36M | -2.95M | -2.76M | -3.93M | -6.28M |
| EPS | -0.03 | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 9.65M | 20.9M | 13.6M | 17.0M | 10.5M | 6.42M | 5.38M | 5.23M | 2.88M | 2.33M |
| Total Liabilities | 9.43M | 11.5M | 13.1M | 9.10M | 6.30M | 4.85M | 6.36M | 1.93M | 3.28M | 2.68M |
| Shareholders' Equity | 219K | 9.45M | 546K | 7.91M | 4.18M | 1.58M | -983K | 3.30M | -402K | -343K |
| Cash & Short-term Investments | 3.41M | 14.4M | 5.48M | 6.91M | 2.93M | 1.03M | 513K | 2.05M | 662K | 217K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -9.80M | -5.56M | -4.34M | -3.18M | -1.39M | -1.57M | -1.10M | - | - | - |
| Capital Expenditure | 1.20M | 41.8K | 90.7K | 102K | 112K | 52.4K | 18.8K | 156K | 218K | 7.85K |
| Free Cash Flow | -14.3M | -8.47M | -7.81M | -6.38M | -2.28M | -1.93M | -1.49M | -1.35M | -2.80M | -3.26M |
| Ratios | ||||||||||
| ROE | -5,538.4% | -56.7% | -1,811.9% | -112.9% | -34.6% | -213.3% | - | -83.6% | - | - |
| ROA | -126.0% | -25.6% | -72.6% | -52.5% | -13.8% | -52.3% | -54.8% | -52.8% | -136.5% | -269.1% |
| Net Profit Margin | -51.0% | -33.3% | -137.2% | -100.8% | -19.9% | -41.1% | -40.9% | -46.8% | -100.1% | -148.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Alexium International Group Limited dividends
Alexium International Group Limited has not paid dividends in the last 10 fiscal years.
Who owns Alexium International Group Limited
- Insiders 25.83%
- Institutions 61.86%
- Public & others 12.31%
- Shares outstanding 3.18B
- Free float 772M
Alexium International Group Limited company profile
- Company name
- Alexium International Group Limited
- Ticker
- E7T.F
- ISIN
- AU000000AJX6
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Fiscal year end
- June
- Address
- 350 West Phillips Road, Greer, SC, United States, 29650
- Phone
- 803-715-3641
- Website
- alexiuminternational.com
About Alexium International Group Limited
Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; Eclipsys, a perpetual cooling technology that enhance the cooling experience; and DelCool, a thermal management product. The company also provides flame retardant solutions, including Alexiflam, a flame-retardant treatment for cotton and cellulose-based textiles; AlexiGuard, a flame-retardant emulsion tailored for 100% polyester fabric; and AlexiShield, a water-resistant flame-retardant solution for providing enhanced flame resistance in mattresses. In addition, it offers Nextek, a mPCM technology delivering high thermal stability with robust capsule walls; Vivtek, a single integrated solution combining a strong, versatile capsule wall with a bio-based core; and microencapsulated PCM technologies. It serves furniture, bedding and mattress, defense, performance apparel, building materials, electronics, life science and medical devices, packaging and logistics, personal comfort and safety, and transportation markets. The company is headquartered in Greer, South Carolina.
Alexium International Group Limited management
6- Mr. William Timothy Blackburn Jr.CEO, MD & Director
- Mr. Randall T. LaneChief Operating Officer
- Ms. Heather McClainVice President of Finance
- Mr. Nicholas LeitnerVice President of Technology
- Ms. Leia HerringHuman Resources Manager
- Ms. Sandra McIntoshCompany Secretary